Literature DB >> 24879917

The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer.

Jung Ho Shim1, Jung Hwan Yoon2, Sung Sook Choi3, Hassan Ashktorab4, Duane T Smoot4, Kyo Young Song1, Suk Woo Nam2, Jung Young Lee2, Cho Hyun Park1, Won Sang Park5.   

Abstract

We investigated whether Helicobacter pylori (H. pylori) CagA contributes to the DNA copy change and mRNA transcript expression of the HER-2 gene and, consequently, affects HER-2 protein expression to evaluate the significance of CagA and HER-2 amplification in gastric cancer. We used the AGS and MKN1 gastric cancer and HFE-145 immortalized non-neoplastic gastric mucosa cell lines. We also confirmed the effects of CagA on HER-2 expression in human gastric cancer tissues and gastric mucosal tissues of H. pylori infected C57BL/6 mice. Ectopic CagA expression in AGS, MKN1 and HFE-145 cells showed a significant increase in HER-2 gene copy number and expression. The gastric mucosae of H. pylori infected C57BL/6 mice also showed increased HER-2 DNA copy number and protein expression. In addition, CagA expression was detected in 17 (56.7%) of 30 gastric cancer tissues, and eight (47%) of them showed HER-2 DNA amplification of more than two-fold. In immunohistochemistry, HER-2 overexpression was detected in 12 (40%) of 30 gastric cancers and a positive correlation was observed among DNA copy number, the mRNA transcript, and protein expression of the HER-2 gene in gastric cancer (P<0.05). These results suggest that H. pylori CagA may induce overexpression of the HER-2 protein by increasing HER-2 DNA and mRNA copy number.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CagA; DNA amplification; Gastric cancer; H. pylori; HER-2/neu

Mesh:

Substances:

Year:  2014        PMID: 24879917      PMCID: PMC4286173          DOI: 10.1016/j.gene.2014.05.064

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  33 in total

1.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

2.  Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection.

Authors:  Karen Guillemin; Nina R Salama; Lucy S Tompkins; Stanley Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-31       Impact factor: 11.205

3.  Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.

Authors:  Y Yonemura; I Ninomiya; A Yamaguchi; S Fushida; H Kimura; S Ohoyama; I Miyazaki; Y Endou; M Tanaka; T Sasaki
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

4.  Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells.

Authors:  Jae J Kim; Hong Tao; Emilia Carloni; Wai K Leung; David Y Graham; Antonia R Sepulveda
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

5.  Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.

Authors:  T Mizutani; M Onda; A Tokunaga; N Yamanaka; Y Sugisaki
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

6.  Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

Authors:  Manuel R Amieva; Roger Vogelmann; Antonello Covacci; Lucy S Tompkins; W James Nelson; Stanley Falkow
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

7.  Significance of erbB-2 gene product as a target molecule for cancer therapy.

Authors:  T Ishida; M Tsujisaki; Y Hanzawa; T Hirakawa; Y Hinoda; K Imai; A Yachi
Journal:  Scand J Immunol       Date:  1994-05       Impact factor: 3.487

Review 8.  Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.

Authors:  A Tokunaga; M Onda; T Okuda; T Teramoto; I Fujita; T Mizutani; T Kiyama; T Yoshiyuki; K Nishi; N Matsukura
Journal:  Cancer       Date:  1995-03-15       Impact factor: 6.860

Review 9.  Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell.

Authors:  A Covacci; R Rappuoli
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

10.  Her2/neu testing in gastric cancer: evaluating the risk of sampling errors.

Authors:  V S Warneke; H-M Behrens; C Böger; T Becker; F Lordick; M P A Ebert; C Röcken
Journal:  Ann Oncol       Date:  2012-11-08       Impact factor: 32.976

View more
  5 in total

Review 1.  Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.

Authors:  L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

2.  A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma.

Authors:  Xinrui Wu; Aiwen Jian; Haidan Tang; Wangrui Liu; Fengyuan Liu; Shifan Liu; Huiqun Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-10       Impact factor: 6.073

Review 3.  Type IV Secretion and Signal Transduction of Helicobacter pylori CagA through Interactions with Host Cell Receptors.

Authors:  Steffen Backert; Nicole Tegtmeyer
Journal:  Toxins (Basel)       Date:  2017-03-24       Impact factor: 4.546

Review 4.  Host pathogen interactions in Helicobacter pylori related gastric cancer.

Authors:  Magdalena Chmiela; Zuzanna Karwowska; Weronika Gonciarz; Bujana Allushi; Paweł Stączek
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

5.  The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.

Authors:  Qi Yao; Lanzhen He; Xucan Gao; Na Tang; Lifen Lin; Xiaofang Yu; Dong Wang
Journal:  Front Oncol       Date:  2021-08-12       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.